Back

Intracoronary nicardipine to induce hypaeremia

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Physiology matters: pushing the boundaries of invasive functional assessment applications Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Thabo Mahendiran

Cardiovascular Research Center Aalst, Aalst (Belgium)

7 More presentations in this session

Presentation thumbnail
Cycling coupled to intra-coronary thermodilution to evaluate angina with non-obstructive coronary artery disease
Doctor G. Rahoual (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Safety and feasibility of nationwide invasive coronary function testing in patients with angina and no obstructive coronary artery disease (NL-CFT).
Ms C. Crooijmans (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Absolute coronary flow and microvascular resistance before and after TAVR
Doctor E. Gallinoro (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Comparison of adenosine, dobutamine and bicycle exercise on intracoronary physiological indices in patients with myocardial bridges
Doctor A. Sinha (London, GB)
Abstract Slides Video
Presentation thumbnail
Coronary microvascular dysfunction in heart failure: observations from the MICRO registry
Doctor O. Velollari (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Physiology matters: pushing the boundaries of invasive functional assessment applications

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Arrhythmia prevention protocol during papaverine administration for invasive coronary functional assessment
thumbnail
Congress Presentation
Cycling coupled to intra-coronary thermodilution to evaluate angina with non-obstructive coronary artery disease
thumbnail
Congress Presentation
Index of microvascular resistance (IMR) and fractional flow reserve (FFR) relationship in patients with angina and non-obstructive coronary artery (ANOCA) disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources